If your asthma has become harder to control in your forties — more reliever use, worse at night, or appearing for the first time after decades without it — that is a documented pattern rather than bad luck. Asthma in women shifts around hormonal transitions, and perimenopause is one of them. It is also one of the least discussed interactions in menopause care.

Where we stand: Menova is an independent publication. We sell no hormones and no medication, we are not your doctor, and this is general education, not medical advice. Never reduce or stop asthma medication on your own.

What the pattern looks like

Two distinct experiences, both reported:

  • Existing asthma becoming harder to control — more symptoms, more reliever inhaler use, worse night-time symptoms, more exacerbations
  • New-onset asthma in midlife, which is more common in women than men and often surprises people who have never had it

Adult-onset asthma in women also tends to be less allergic in character than childhood asthma, which is part of why it can be missed — the usual triggers may not apply.

Why hormones are implicated

Sex hormones influence airway inflammation and airway smooth muscle, and asthma severity in women often varies with the menstrual cycle — perimenstrual worsening is a recognized pattern. In perimenopause, when estrogen and progesterone fluctuate erratically rather than cyclically, that variability can become unpredictable.

Two other contributors specific to this decade:

  • Weight change, since higher body weight is associated with worse asthma control
  • Reflux, which worsens asthma and becomes more common in midlife

The symptoms that get confused

This matters because it cuts both ways.

Breathlessness attributed to asthma may be anemia from heavy perimenopausal periods — see low ferritin in perimenopause — or a cardiac issue, which is under-recognized in women; see heart health in menopause.

Night-time waking and breathlessness may be asthma, or sleep apnea, which rises sharply after menopause and frequently coexists with asthma; see sleep apnea after menopause.

Palpitations and breathlessness with a wave of heat may be a vasomotor episode rather than an asthma attack — or the reverse; see palpitations in perimenopause.

The practical response is not to guess: if your breathing has changed, that deserves objective assessment rather than attribution.

Does HRT help or hurt?

The honest answer is that the evidence is mixed and this is not settled.

Some observational research has associated hormone therapy with increased asthma incidence or symptoms in some women; other work has found improvement in women whose asthma clearly fluctuates with hormonal change. Reviews generally conclude the relationship is complex and individual.

What follows practically:

  • Asthma is not a barrier to hormone therapy, but it is a reason to monitor
  • Track your peak flow or symptom score for a few weeks before and after starting, so you have data rather than an impression
  • Tell both clinicians. The person managing your asthma should know you have started HRT, and vice versa
  • If your asthma worsens after starting, that is a specific, actionable observation — dose, route, or the progestogen component can be changed rather than abandoning treatment. See HRT types and forms and is HRT safe

The medication interaction that matters for bone

Worth knowing in this specific decade: long-term oral corticosteroids are an established risk factor for bone loss, and frequent courses for exacerbations add up. Bone loss also accelerates around menopause independently.

If you have needed several steroid courses, that combination is a reason to discuss a bone density scan and to be deliberate about calcium, vitamin D, and resistance training — see bone health in menopause and medications that affect bone.

Inhaled steroids at standard doses carry far less bone risk than oral courses; the concern is repeated systemic exposure, not your preventer inhaler.

What actually helps control

  • Get your technique checked. Inhaler technique degrades over years and is one of the most common reasons control slips. A pharmacist can review it free
  • Use the preventer as prescribed, including when you feel well. Increasing reliever use is a signal to review, not a solution
  • Ask for a written asthma action plan if you do not have one — they measurably reduce exacerbations
  • Track peak flow if your control has become unpredictable. It converts "it feels worse" into evidence
  • Treat reflux if present
  • Address weight and fitness, where relevant. Exercise improves asthma control rather than threatening it, though warming up properly matters more now; see exercise in midlife
  • Sleep and stress, both of which affect control; see perimenopause sleep problems
  • Stop smoking, which is the single largest modifiable factor here; see smoking and menopause

Seek urgent care if

  • Your reliever inhaler is not helping, or the effect wears off quickly
  • You are too breathless to speak in full sentences
  • Your breathing is getting worse rapidly
  • Your peak flow drops well below your usual best

Do not wait these out on the assumption they are hormonal.

What to say

"My asthma control has got worse over the past year, alongside my periods changing. I know hormones can affect asthma. Could we review my inhaler technique and my action plan — and if I start hormone therapy, how should we monitor my asthma?"

That gets both conditions onto the same page, which is the failure mode here: the respiratory review does not ask about hormones, and the menopause consultation does not ask about breathing.

Our free 30-day symptom tracker has a note column that works alongside a peak flow diary, and the free printable visit prep sheet gives you one page for both. The free 2-minute self-check organizes the menopausal side — no account, not a diagnosis, and your answers never leave your device.

This article is general education, not medical advice. Asthma requires assessment and management by a licensed clinician. Never reduce or stop asthma medication on your own, and seek urgent care for the warning signs above.

Sources: NHLBI — Asthma, Global Initiative for Asthma (GINA), The Menopause Society, and NHS — Asthma.